In the current study, we characterized the repertoire of IgG and IgA autoantibodies present in the BC and normal breast tissue supernatants and plasma of BC patients and controls using our in-house 91-antigen microarrays, and analyzed the relationship between the presence of autoantibodies and clinical, histological and immunological features of tumors. This evidence concerns the gene CD79A and breast cancer.